RT Journal Article
SR Electronic
T1 Non-cardiac surgery and antiplatelet therapy following coronary artery stenting
JF Heart
JO Heart
FD BMJ Publishing Group Ltd and British Cardiovascular Society
SP 1303
OP 1308
DO 10.1136/hrt.2008.161273
VO 95
IS 16
A1 Luckie, M
A1 Khattar, R S
A1 Fraser, D
YR 2009
UL http://heart.bmj.com/content/95/16/1303.abstract
AB Coronary artery stenting is increasingly used as a treatment for coronary artery disease. A period of antiplatelet therapy is mandatory following coronary stenting, in order to minimise the risk of stent thrombosis. About 5% of patients who undergo coronary stenting will require non-cardiac surgery within 12 months, and the management of antiplatelet therapy in this setting is complex, requiring a balance between the risks of both operative haemorrhage and stent thrombosis. The available evidence to guide decision-making in the management of antiplatelet therapy in this setting is reviewed.